Page 10 - CIBERES2016-ENG

Significant activities
Projects
NATIONAL
Financing Agency: Instituto de Salud Carlos III
Role of innate immune receptors in vascular alterations associated with acute lung damage and pulmonary hypertension. The implication of endogenous danger-associated molecular patterns. Role of FAS-mediated apoptosis in damage of the pulmonary epithelium.
Identification of markers of very severe COPD activity in experimental models, and assessment of therapeutic intervention with soluble guanylate cyclase.
National Biobanks Network.
Molecular profile of cardiovascular risk in patients with obstructive sleep apnoea: Personalised predictive model.
FPI Cohort: Telomere Shortening and its regulation.
Therapeutic potential of exosomes derived from mesenchymal cells and late endothelial progenitor cells in bronchopulmonary dysplasia and pulmonary hypertension.
Tight junctions of the alveolar epithelium in the development of the Acute Respiratory Distress Syndrome: Clinical and experimental study.
Financing Agency: Ministry of the Economy and Competitiveness:
Post-Doctoral Grant Contract 2013. Technical Support staff Contract 2015.
Other financing organisations:
Fundación Astrazeneca.
Development and application of network medicine to tackle pathobiological heterogeneity and clinical complexity of COPD.
Impact of the Sleep apnoea-hypopnea syndrome in the evolution of the acute coronary syndrome. Effect of intervention with continuous positive airway pressure (CPAP).
INTERNATIONAL PROJECTS EU FP7-PEOPLE-2011-COFUND Proyecto M+VISION.
Transfer
One of the CIBER’s main aims is the transfer of the knowledge generated by its researchers, so that its research results can be developed in protocols, services and products for improving clinical practice and people’s quality of life.
To this end the CIBER Technology Transfer department acts as a liaison between our researchers and companies, private institutions, public research centres and other innovation agents to make cooperation with them more effective and ensure that the results of research are actually applied.
Work is done in several approaches to achieve this aim:
• Continuous contact with our researchers to monitor their results and train them in innovation management.
On 29 and 30 November 2016 a Technology Transfer Session was arranged to this end as part of the 30th anniversary of the ISCIII. At this event experts in different areas shared their knowledge on industrial property, company creation, licencing processes, venture capital, grants for internationalisation, etc.
• Protection of the results of research and management of cooperation with other agents, as displayed by the application for patents and signing licence contracts, amongst other agreements.
1203